Lista de obras -

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report.

artículo científico publicado en 2013

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

artículo científico publicado en 2018

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

artículo científico publicado en 2017

Angiogenesis and antiangiogenic agents in cervical cancer.

artículo científico publicado en 2014

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

artículo científico

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

artículo científico publicado en 2018

Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.

artículo científico

Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial

scientific article published on 02 September 2014

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

artículo científico

Current status of bevacizumab in advanced ovarian cancer

artículo científico publicado en 2013

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

artículo científico publicado en 2013

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

artículo científico publicado en 2013

Emerging biological treatments for uterine cervical carcinoma.

artículo científico publicado en 2014

Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

artículo científico publicado en 2013

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).

artículo científico publicado en 2013

Fertility drugs, reproductive strategies and ovarian cancer risk.

artículo científico publicado en 2014

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

artículo científico publicado en 2013

Immunologic treatments for precancerous lesions and uterine cervical cancer

artículo científico publicado en 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.

artículo científico

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

artículo científico publicado en 2013

Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors

scientific article published on 10 September 2019

Niraparib in ovarian cancer: results to date and clinical potential.

artículo científico publicado en 2017

Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.

artículo científico publicado en 2018

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

artículo científico publicado en 2019

Triple-negative breast cancer: new perspectives for targeted therapies.

artículo científico publicado en 2015

Lista de obras de

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Angiogenesis and antiangiogenic agents in cervical cancer.

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.

Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

Current status of bevacizumab in advanced ovarian cancer

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Emerging biological treatments for uterine cervical carcinoma.

Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).

Fertility drugs, reproductive strategies and ovarian cancer risk.

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

Immunologic treatments for precancerous lesions and uterine cervical cancer

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors

Niraparib in ovarian cancer: results to date and clinical potential.

Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

Triple-negative breast cancer: new perspectives for targeted therapies.